Based on the available information, the organization that owns Ozempic is Novo Nordisk. This is stated in the first source, a patent watch website, which lists Novo Nordisk as the assignee for the Ozempic trademark [1]. The second and third sources, both news articles from the New York Times and CNBC, also refer to Novo Nordisk as the manufacturer of Ozempic, further supporting this [2][3].

To provide some context, Ozempic is a medication used to treat type 2 diabetes and, more recently, has been used off-label for weight loss. The drug has seen a surge in popularity, leading to increased demand and supply shortages [2]. Novo Nordisk, a Danish pharmaceutical company, is the organization that developed and markets Ozempic [3].

In summary, based on the available information, Novo Nordisk is the organization that owns Ozempic.

[1] <https://www.drugpatentwatch.com/p/tradename/OZEMPIC>
[2] <https://www.nytimes.com/2023/10/22/health/ozempic-wegovy-price-cost.html>
[3] <https://www.cnbc.com/2023/10/10/ozempic-wegovy-novo-nordisk.html>